VNRX Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: November 24, 2025

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for VolitionRX Ltd (VNRX)

Based on 11 analysts giving stock ratings to VolitionRX Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
18
Buy
64
Hold
18
Sell
0
Strong Sell
0
VolitionRX Ltd

VolitionRX Ltd. Stock Analysis VNRX

United States Health Care Nano Cap Report:
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Henderson, Nevada and currently employs 85 full-time employees. The company went IPO on 2015-02-06. The firm is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Read More

VolitionRX Ltd (VNRX) Chart

Key Statistics of VolitionRX Ltd (VNRX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.18$0.20

Today's Open

$0.19

Volume

7.21M

P/E Ratio (TTM)

-

52 Week Range

$0.17$0.94

Market Cap

35.00M

Avg. Volume

19.17M

Dividend Yield

-

Financial Metrics & Statements of VolitionRX Ltd (VNRX)

FAQ's for VolitionRX Ltd (VNRX)

  • According to Musaffa’s Shariah screening methodology, VolitionRX Ltd (VNRX) is currently classified as NOT HALAL as of November 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.